Clinical Trial: A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure

U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT07562087) titled 'A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure' on March 30.

Brief Summary: This study is designed to evaluate the safety, tolerability, and pharmacokinetics of TP05 administered orally to healthy adult participants.

Study Start Date: March 09

Study Type: INTERVENTIONAL

Condition: Lyme Disease

Intervention: DRUG: TP-05 (lotilaner) Low Dose

TP05 administered orally at the protocol-defined preventative dose.

DRUG: TP-05 (lotilaner) High Dose

TP05 administered orally at the protocol-defined preventative dose.

DRUG: Placebo

Matching placebo administered orally according to the same d...